UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 251

Sortiert nach

Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease

The American journal of gastroenterology, 2022-03, Vol.117 (3), p.453-461

2022

Link zum Volltext

Verfügbarkeit prüfen

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

Liver international, 2020-08, Vol.40 (8), p.1841-1852

2020

Link zum Volltext

Verfügbarkeit prüfen

Steroid-sparing effect of belimumab: results from a retrospective observational study of real-world data

Lupus science & medicine, 2023-12, Vol.10 (2), p.e001024

2023

Link zum Volltext

Verfügbarkeit prüfen

Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD

Hepatology communications, 2022-04, Vol.6 (4), p.765-779

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Age-Stratified FVIII Consumption and Bleed Outcomes Before and After Switching to Rurioctocog Alfa Pegol in a Retrospective, Observational Study Using US Specialty Pharmacy Data

Blood, 2019-11, Vol.134 (Supplement_1), p.2411-2411

2019

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real-world patient data repository

Pulmonary circulation, 2023-07, Vol.13 (3), p.e12258-e12258

2023

Link zum Volltext

Verfügbarkeit prüfen

Hearing the voice of faculty: Global recommendations for faculty recognition in Higher Education institutions

Higher learning research communications, 2018-12, Vol.8 (2), p.1-8

2018

Link zum Volltext

Verfügbarkeit prüfen

First‐line therapies for hepatitis B in the United States: A 3‐year prospective and multicenter real‐world study after approval of tenofovir alefenamide

Hepatology communications, 2022-08, Vol.6 (8), p.1881-1894

2022

Link zum Volltext

Verfügbarkeit prüfen

Processing, Localization, and Requirement of Human Separase for Normal Anaphase Progression

Proceedings of the National Academy of Sciences - PNAS, 2003-04, Vol.100 (8), p.4574-4579

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical Practice Utilization and Outcomes with Rasburicase Vs Allopurinol for Patients at High Risk of Tumor Lysis Syndrome

Blood, 2019-11, Vol.134 (Supplement_1), p.2203-2203

2019

Link zum Volltext

Verfügbarkeit prüfen

The Phosphatidylinositol Transfer Protein Domain of Drosophila Retinal Degeneration B Protein Is Essential for Photoreceptor Cell Survival and Recovery from Light Stimulation

The Journal of cell biology, 1997-10, Vol.139 (2), p.351-363

1997

Link zum Volltext

Verfügbarkeit prüfen

Effect of intrarow plant spacing on the effectiveness of family selection in sugarcane: Selection indices

Interciencia, 2009-12, Vol.34 (12), p.893-896

2009

Link zum Volltext

Verfügbarkeit prüfen

SAT-310-Real-world evaluation of NASH in US clinical practice: Underutilization of liver biopsy and liver imaging

Journal of hepatology, 2019-04, Vol.70 (1), p.e775-e776

2019

Link zum Volltext

Verfügbarkeit prüfen

A Retrospective Observational Study of Rurioctocog Alfa Pegol in Clinical Practice in the United States

Journal of managed care & specialty pharmacy, 2020-04, Vol.26 (4), p.492

2020

Link zum Volltext

Verfügbarkeit prüfen

Early Stage Sugarcane Selection Using Different Plot Sizes

Crop science, 2007-09, Vol.47 (5), p.1859-1864

2007

Link zum Volltext

Verfügbarkeit prüfen

SAT387 - Pangenotypic therapies glecaprevir-pibrentasvir (G-P) and sofosbuvir-velpatasvir-voxilaprevir (S-V-V) after failure with interferon (IFN)-free direct-acting antiviral (DAA) treatment for hepatitis C

Journal of hepatology, 2020-08, Vol.73, p.S846-S847

2020

Link zum Volltext

Verfügbarkeit prüfen

Use of GLP-1 receptor agonists (GLP1A) and/or SGLT-2 inhibitors (SGLT2I) in populations with NASH or at risk of NASH in US clinical practice

Journal of hepatology, 2020-08, Vol.73, p.S452

2020

Link zum Volltext

Verfügbarkeit prüfen

FRI107 - Use of GLP-1 receptor agonists (GLP1A) and/or SGLT-2 inhibitors (SGLT2I) in populations with NASH or at risk of NASH in US clinical practice

Journal of hepatology, 2020-08, Vol.73, p.S452-S452

2020

Link zum Volltext

Verfügbarkeit prüfen

THU435 - Drug-drug interactions (DDIs) with pangenotypic direct-acting antivirals (DAAs) in patients with hepatitis C; understanding the populations at risk and real-world care management

Journal of hepatology, 2020-08, Vol.73, p.S355-S356

2020

Link zum Volltext

Verfügbarkeit prüfen

Pangenotypic therapies glecaprevir-pibrentasvir (G-P) and sofosbuvir-velpatasvir-voxilaprevir (S-V-V) after failure with interferon (IFN)-free direct-acting antiviral (DAA) treatment for hepatitis C

Journal of hepatology, 2020-08, Vol.73, p.S846-S847

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug-drug interactions (DDIs) with pangenotypic direct-acting antivirals (DAAs) in patients with hepatitis C; understanding the populations at risk and real-world care management

Journal of hepatology, 2020-08, Vol.73, p.S355-S356

2020

Link zum Volltext

Verfügbarkeit prüfen

Tu1670 USE OF GLP-1 RECEPTOR AGONISTS (GLP1A) AND/OR SGLT-2 INHIBITORS (SGLT2I) IN POPULATIONS WITH NASH OR AT RISK OF NASH IN US CLINICAL PRACTICE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1446-S-1446

2020

Link zum Volltext

Verfügbarkeit prüfen

Economic Inequality, Poverty, and Tolerance: Evidence from 22 Countries

Comparative sociology, 2012-01, Vol.11 (4), p.594-619

Milligan, Scott

2012

Link zum Volltext

Verfügbarkeit prüfen

965 – Real-World Evaluation of Nash in US Clinical Practice: Underutilization of Liver Biopsy and Liver Imaging

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1223-S-1223

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 251

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(219)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

Steroid-sparing effect of belimumab: results from a retrospective observational study of real-world data

Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders

Real-World Age-Stratified FVIII Consumption and Bleed Outcomes Before and After Switching to Rurioctocog Alfa Pegol in a Retrospective, Observational Study Using US Specialty Pharmacy Data

Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real-world patient data repository

Hearing the voice of faculty: Global recommendations for faculty recognition in Higher Education institutions

First‐line therapies for hepatitis B in the United States: A 3‐year prospective and multicenter real‐world study after approval of tenofovir alefenamide

Processing, Localization, and Requirement of Human Separase for Normal Anaphase Progression

Clinical Practice Utilization and Outcomes with Rasburicase Vs Allopurinol for Patients at High Risk of Tumor Lysis Syndrome

The Phosphatidylinositol Transfer Protein Domain of Drosophila Retinal Degeneration B Protein Is Essential for Photoreceptor Cell Survival and Recovery from Light Stimulation

Effect of intrarow plant spacing on the effectiveness of family selection in sugarcane: Selection indices

SAT-310-Real-world evaluation of NASH in US clinical practice: Underutilization of liver biopsy and liver imaging

A Retrospective Observational Study of Rurioctocog Alfa Pegol in Clinical Practice in the United States

Early Stage Sugarcane Selection Using Different Plot Sizes

SAT387 - Pangenotypic therapies glecaprevir-pibrentasvir (G-P) and sofosbuvir-velpatasvir-voxilaprevir (S-V-V) after failure with interferon (IFN)-free direct-acting antiviral (DAA) treatment for hepatitis C

Use of GLP-1 receptor agonists (GLP1A) and/or SGLT-2 inhibitors (SGLT2I) in populations with NASH or at risk of NASH in US clinical practice

FRI107 - Use of GLP-1 receptor agonists (GLP1A) and/or SGLT-2 inhibitors (SGLT2I) in populations with NASH or at risk of NASH in US clinical practice

THU435 - Drug-drug interactions (DDIs) with pangenotypic direct-acting antivirals (DAAs) in patients with hepatitis C; understanding the populations at risk and real-world care management

Pangenotypic therapies glecaprevir-pibrentasvir (G-P) and sofosbuvir-velpatasvir-voxilaprevir (S-V-V) after failure with interferon (IFN)-free direct-acting antiviral (DAA) treatment for hepatitis C

Drug-drug interactions (DDIs) with pangenotypic direct-acting antivirals (DAAs) in patients with hepatitis C; understanding the populations at risk and real-world care management

Tu1670 USE OF GLP-1 RECEPTOR AGONISTS (GLP1A) AND/OR SGLT-2 INHIBITORS (SGLT2I) IN POPULATIONS WITH NASH OR AT RISK OF NASH IN US CLINICAL PRACTICE

Economic Inequality, Poverty, and Tolerance: Evidence from 22 Countries

965 – Real-World Evaluation of Nash in US Clinical Practice: Underutilization of Liver Biopsy and Liver Imaging

Suchergebnisse filtern